Russian Tuberculosis Clinics Get Minilabs to Prevent Fake Medicines
Three tuberculosis clinics in Russia have been equipped with GPHF-Minilabs, mobile mini-laboratories supplied by the Global Pharma Health Fund (GPHF), to protect patients from being treated with counterfeit medicines, the proliferation of which is a burning problem in Russia.
These small laboratories can quickly verify drug quality and detect counterfeit medicines, making it possible for doctors at clinics in Moscow, Russia’s capital, and the cities of Vladimir and Orel in the western part of the country, to get rid of counterfeit pharmaceuticals that could increase the spread of drug-resistant strains of tuberculosis.
For more information, please contact Jelena Jankovic at our Balkan Regional Office.
May 2010 News
- Bulgaria Adopts Draft Law Amending the Law on Industrial Design
- New Rules on Patent and Industrial Design Extension in Azerbaijan
- Polish Court Dismisses Vegeta Suit Against Hungarian Spice Producer
- First Cyrillic Domain Launched in Russia
- Bulgarian Snack Food Manufacturer Fined Over Misleading TV Commercial
- U.S. Removes Czech Republic, Hungary, Poland from IP Watch List, Condemns Russia for Weak IP Protection
- Bill Tightening Penalties for Copyright Violation Introduced in Armenian Parliament
- Bosnia Working on New Customs Regulations for Protection of IPR
- Romanian Customs Detain Counterfeit Sneakers, Apparel, Cosmetics
- Macedonian Customs Seize Designer Clothes from Illegal Boutique
- Serbian Customs Seize Counterfeit Watches, Cell Phones
- Russian Tuberculosis Clinics Get Minilabs to Prevent Fake Medicines
- Slovenia Files Fewer Applications with EPO in 2009
- Lithuanian PTO Launches Electronic Patent Database
- AmCham Macedonia Prepares Guide for Protection of Trademarks
- Bulgaria PTO President Elected to OHIM Budget Committee
- In Romania All Pending Trademark Applications Now Online